Trajectories of Serum NfL and GFAP Levels in Newly Diagnosed Multiple Sclerosis Patients After Initiation of Immunomodulatory Treatments (P6-1.012)
This study aimed to describe the dynamics of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels and explore their association with disease activity in multiple sclerosis (MS).
Authors
- Manuela Vaněčková (ORCID: https://orcid.org/0000-0002-8784-7997)
- Dana Horáková (ORCID: https://orcid.org/0000-0003-1915-0036)
- Tomáš Uher (ORCID: https://orcid.org/0000-0003-3160-9022)
- Barbora Srpová (ORCID: https://orcid.org/0000-0002-8092-6625)
- Jens Kühle (ORCID: https://orcid.org/0000-0002-6963-8892)
- Aleksandra Maleska
- Eva Havrdová (ORCID: https://orcid.org/0000-0002-9543-4359)
- Pascal Benkert (ORCID: https://orcid.org/0000-0001-6525-8174)
- Václav Čapek (ORCID: https://orcid.org/0000-0002-8574-7001)
Institutions
- University of Basel (CH)
- Charles University (CZ)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211708
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00